Hypoxia is a distinct feature of malignant solid tumors, which is a possible causative factor for the serious resistance to chemo- and radiotherapy or the development of invasion and metastasis. The exploration of nanosensors with the capabilities like the accurate diagnosis of hypoxic level will be helpful to estimate the malignant degree of tumor and subsequently implement more effective personalized treatment. Here, we report the design and synthesis of nanosensors that can selectively and reversibly detect the level of hypoxia both in vitro and in vivo. The designed nanosensor is composed of two main moieties: oxygen indicator [Ru(dpp)<sub>3</sub>]<sup>2+</sup>Cl<sub>2</sub> for detection of hypoxia and upconversion nanoparticles for o...
We developed a novel near-infrared (NIR) fluorescent probe, GPU-167, for <i>in vivo</i> imaging of t...
Oxygen is a crucial reagent in many biochemical processes within living cells and its concentration ...
The diagnosis of cancer in early stages is an unmet clinical need, especially in view that current ...
Hypoxia is a distinct feature of malignant solid tumors, which is a possible causative factor for th...
The development of sensors for noninvasive determination of oxygen levels in live cells and tissues ...
Real-time monitoring of oxygen consumption is beneficial to predict treatment responses and optimize...
Hypoxia detection is emphasized with attention due to tumor and related diseases diagnosis, which co...
Oxygen is a critical component for many physiological and pathological processes in living cells.[1,...
Hypoxia is a common feature of tumor cells. Nitroreductase (NTR), a common biomarker of hypoxia, has...
Abstract Background Tumor hypoxia is a characteristic of paramount importance due to low oxygenation...
A quantum-dot based ratiometric fluorescent oxygen probe for the detection of hypoxia in live cells ...
Hypoxia is a common characteristic of solid tumors, which is caused by the imbalance of oxygen suppl...
Metal complex-based luminescent oxygen nanosensors have been intensively studied for biomedical appl...
Nitroreductase (NTR) with a high expression level in tumors has been considered as a biomarker of hi...
Nanophotonic biosensors capable of being excited in the NIR spectrum have applications in various se...
We developed a novel near-infrared (NIR) fluorescent probe, GPU-167, for <i>in vivo</i> imaging of t...
Oxygen is a crucial reagent in many biochemical processes within living cells and its concentration ...
The diagnosis of cancer in early stages is an unmet clinical need, especially in view that current ...
Hypoxia is a distinct feature of malignant solid tumors, which is a possible causative factor for th...
The development of sensors for noninvasive determination of oxygen levels in live cells and tissues ...
Real-time monitoring of oxygen consumption is beneficial to predict treatment responses and optimize...
Hypoxia detection is emphasized with attention due to tumor and related diseases diagnosis, which co...
Oxygen is a critical component for many physiological and pathological processes in living cells.[1,...
Hypoxia is a common feature of tumor cells. Nitroreductase (NTR), a common biomarker of hypoxia, has...
Abstract Background Tumor hypoxia is a characteristic of paramount importance due to low oxygenation...
A quantum-dot based ratiometric fluorescent oxygen probe for the detection of hypoxia in live cells ...
Hypoxia is a common characteristic of solid tumors, which is caused by the imbalance of oxygen suppl...
Metal complex-based luminescent oxygen nanosensors have been intensively studied for biomedical appl...
Nitroreductase (NTR) with a high expression level in tumors has been considered as a biomarker of hi...
Nanophotonic biosensors capable of being excited in the NIR spectrum have applications in various se...
We developed a novel near-infrared (NIR) fluorescent probe, GPU-167, for <i>in vivo</i> imaging of t...
Oxygen is a crucial reagent in many biochemical processes within living cells and its concentration ...
The diagnosis of cancer in early stages is an unmet clinical need, especially in view that current ...